Scott Wieland
2013
In 2013, Scott Wieland earned a total compensation of $706.8K as Senior Vice President – Drug Development at CytRx.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $256,800 |
| Salary | $350,000 |
| Total | $706,800 |
Wieland received $350K in salary, accounting for 50% of the total pay in 2013.
Wieland also received $100K in bonus and $256.8K in option awards.
Rankings
In 2013, Scott Wieland's compensation ranked 8,084th out of 12,286 executives tracked by ExecPay. In other words, Wieland earned more than 34.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,084 out of 12,286 | 34th |
Division Manufacturing | 2,927 out of 4,612 | 37th |
Major group Chemicals And Allied Products | 909 out of 1,462 | 38th |
Industry group Drugs | 689 out of 1,156 | 40th |
Industry Biological Products, Except Diagnostic Substances | 111 out of 196 | 43rd |
Source: SEC filing on May 20, 2016.
Wieland's colleagues
We found four more compensation records of executives who worked with Scott Wieland at CytRx in 2013.